BRISTOL, Tenn., Aug. 3 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) previously announced that it will provide a live webcast of
its conference call to be held following King's announcement of earnings for
the second quarter ending June 30, 2005. King plans to announce earnings for
the second quarter ending June 30, 2005 prior to the market open on Tuesday,
August 9, 2005.
Interested persons may listen to the conference call on Tuesday, August 9,
2005, at 1:00 p.m., E.D.T. at
http://www.b2i.us/external.asp?b=1084&id=177&from=wc&L=e or by dialing
866-594-7514 (US only) or 706-643-7504 (international). If you are unable to
participate during the live webcast, the call will be archived on King's web
site http://www.kingpharm.com for not less than 14 days following the call. A replay
of the conference call will also be available for not less than 5 days
following the call by dialing 800-408-3053 (US only) or 416-695-5800
(international), passcode 3160335#.
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
About Forward-Looking Statements
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated release of its financial
results and live webcast. These forward-looking statements involve certain
significant risks and uncertainties, and actual results may differ materially
from the forward-looking statements. Some important factors which may cause
results to differ include dependence on King's ability to release its
financial results and conduct its webcast as currently planned on August 9,
2005. Other important factors that may cause actual results to differ
materially from the forward-looking statements are discussed in the "Risk
Factors" section and other sections of King's Form 10-K for the year ended
December 31, 2004 and Form 10-Q for the first quarter ended March 31, 2005
which are on file with the Securities and Exchange Commission. King does not
undertake to publicly update or revise any of its forward-looking statements
even if experience or future changes show that the indicated results or events
will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
